346 results on '"Musella, Alessandra"'
Search Results
2. Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis
3. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis
4. Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation
5. BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis
6. Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
7. Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity
8. Electrophysiology of Endocannabinoid Signaling
9. Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.
10. An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis.
11. Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis
12. Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.
13. MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis
14. Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis.
15. Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis
16. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis
17. Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis
18. Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases
19. Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course
20. Distinct intrathecal inflammatory signatures following relapse and anti- COVID-19 mRNA vaccination in Multiple Sclerosis. A cross-sectional study.
21. Genetic regulation of IL-8 influences disease presentation of multiple sclerosis
22. Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis
23. Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
24. Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis
25. Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis
26. TNF-α-mediated anxiety in a mouse model of multiple sclerosis
27. Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis
28. The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis
29. Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
30. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
31. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis
32. MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis
33. Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis
34. Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis
35. Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis
36. Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis
37. The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission
38. Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis
39. Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis
40. Adaptations of Striatal Endocannabinoid System During Stress
41. The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis
42. Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
43. sj-pdf-1-tan-10.1177_1756286420970833 – Supplemental material for Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients
44. Re-Examining the Role of TNF in MS Pathogenesis and Therapy
45. Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis
46. Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity
47. MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis.
48. A Molecular Carrier to Transport and Deliver Cisplatin into Endometrial Cancer Cells
49. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis
50. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.